Neuroimaging Biomarkers Predicting the Efficacy of Multimodal Rehabilitative Intervention in the Alzheimer’s Dementia Continuum Pathology

In this work we aimed to identify neural predictors of the efficacy of multimodal rehabilitative interventions in AD-continuum patients in the attempt to identify ideal candidates to improve the treatment outcome. Subjects in the AD continuum who participated in a multimodal rehabilitative treatment...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sonia Di Tella, Monia Cabinio, Sara Isernia, Valeria Blasi, Federica Rossetto, Francesca Lea Saibene, Margherita Alberoni, Maria Caterina Silveri, Sandro Sorbi, Mario Clerici, Francesca Baglio
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
MRI
Acceso en línea:https://doaj.org/article/8d2868729e464ae38c2aec2f77f23d0a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8d2868729e464ae38c2aec2f77f23d0a
record_format dspace
spelling oai:doaj.org-article:8d2868729e464ae38c2aec2f77f23d0a2021-11-22T05:22:28ZNeuroimaging Biomarkers Predicting the Efficacy of Multimodal Rehabilitative Intervention in the Alzheimer’s Dementia Continuum Pathology1663-436510.3389/fnagi.2021.735508https://doaj.org/article/8d2868729e464ae38c2aec2f77f23d0a2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnagi.2021.735508/fullhttps://doaj.org/toc/1663-4365In this work we aimed to identify neural predictors of the efficacy of multimodal rehabilitative interventions in AD-continuum patients in the attempt to identify ideal candidates to improve the treatment outcome. Subjects in the AD continuum who participated in a multimodal rehabilitative treatment were included in the analysis [n = 82, 38 Males, mean age = 76 ± 5.30, mean education years = 9.09 ± 3.81, Mini Mental State Examination (MMSE) mean score = 23.31 ± 3.81]. All subjects underwent an MRI acquisition (1.5T) at baseline (T0) and a neuropsychological evaluation before (T0) and after intervention (T1). All subjects underwent an intensive multimodal cognitive rehabilitation (8–10 weeks). The MMSE and Neuropsychiatric Inventory (NPI) scores were considered as the main cognitive and behavioral outcome measures, and Delta change scores (T1–T0) were categorized in Improved (ΔMMSE > 0; ΔNPI < 0) and Not Improved (ΔMMSE ≤ 0; ΔNPI ≥ 0). Logistic Regression (LR) and Random Forest classification models were performed including neural markers (Medial Temporal Brain; Posterior Brain (PB); Frontal Brain (FB), Subcortical Brain indexes), neuropsychological (MMSE, NPI, verbal fluencies), and demographical variables (sex, age, education) at baseline. More than 50% of patients showed a positive effect of the treatment (ΔMMSE > 0: 51%, ΔNPI < 0: 52%). LR model on ΔMMSE (Improved vs. Not Improved) indicate a predictive role for MMSE score (p = 0.003) and PB index (p = 0.005), especially the right PB (p = 0.002) at baseline. The Random Forest analysis correctly classified 77% of cognitively improved and not improved AD patients. Concerning the NPI, LR model on ΔNPI (Improved vs. Not Improved) showed a predictive role of sex (p = 0.002), NPI (p = 0.005), PB index (p = 0.006), and FB index (p = 0.039) at baseline. The Random Forest reported a classification accuracy of 86%. Our data indicate that cognitive and behavioral status alone are not sufficient to identify best responders to a multidomain rehabilitation treatment. Increased neural reserve, especially in the parietal areas, is also relevant for the compensatory mechanisms activated by rehabilitative treatment. These data are relevant to support clinical decision by identifying target patients with high probability of success after rehabilitative programs on cognitive and behavioral functioning.Sonia Di TellaSonia Di TellaMonia CabinioSara IserniaValeria BlasiFederica RossettoFrancesca Lea SaibeneMargherita AlberoniMaria Caterina SilveriMaria Caterina SilveriSandro SorbiSandro SorbiMario ClericiMario ClericiFrancesca BaglioFrontiers Media S.A.articleneurodegenerative diseasesdementiarehabilitationbiomarkerMRIbrain reserveNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Aging Neuroscience, Vol 13 (2021)
institution DOAJ
collection DOAJ
language EN
topic neurodegenerative diseases
dementia
rehabilitation
biomarker
MRI
brain reserve
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle neurodegenerative diseases
dementia
rehabilitation
biomarker
MRI
brain reserve
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Sonia Di Tella
Sonia Di Tella
Monia Cabinio
Sara Isernia
Valeria Blasi
Federica Rossetto
Francesca Lea Saibene
Margherita Alberoni
Maria Caterina Silveri
Maria Caterina Silveri
Sandro Sorbi
Sandro Sorbi
Mario Clerici
Mario Clerici
Francesca Baglio
Neuroimaging Biomarkers Predicting the Efficacy of Multimodal Rehabilitative Intervention in the Alzheimer’s Dementia Continuum Pathology
description In this work we aimed to identify neural predictors of the efficacy of multimodal rehabilitative interventions in AD-continuum patients in the attempt to identify ideal candidates to improve the treatment outcome. Subjects in the AD continuum who participated in a multimodal rehabilitative treatment were included in the analysis [n = 82, 38 Males, mean age = 76 ± 5.30, mean education years = 9.09 ± 3.81, Mini Mental State Examination (MMSE) mean score = 23.31 ± 3.81]. All subjects underwent an MRI acquisition (1.5T) at baseline (T0) and a neuropsychological evaluation before (T0) and after intervention (T1). All subjects underwent an intensive multimodal cognitive rehabilitation (8–10 weeks). The MMSE and Neuropsychiatric Inventory (NPI) scores were considered as the main cognitive and behavioral outcome measures, and Delta change scores (T1–T0) were categorized in Improved (ΔMMSE > 0; ΔNPI < 0) and Not Improved (ΔMMSE ≤ 0; ΔNPI ≥ 0). Logistic Regression (LR) and Random Forest classification models were performed including neural markers (Medial Temporal Brain; Posterior Brain (PB); Frontal Brain (FB), Subcortical Brain indexes), neuropsychological (MMSE, NPI, verbal fluencies), and demographical variables (sex, age, education) at baseline. More than 50% of patients showed a positive effect of the treatment (ΔMMSE > 0: 51%, ΔNPI < 0: 52%). LR model on ΔMMSE (Improved vs. Not Improved) indicate a predictive role for MMSE score (p = 0.003) and PB index (p = 0.005), especially the right PB (p = 0.002) at baseline. The Random Forest analysis correctly classified 77% of cognitively improved and not improved AD patients. Concerning the NPI, LR model on ΔNPI (Improved vs. Not Improved) showed a predictive role of sex (p = 0.002), NPI (p = 0.005), PB index (p = 0.006), and FB index (p = 0.039) at baseline. The Random Forest reported a classification accuracy of 86%. Our data indicate that cognitive and behavioral status alone are not sufficient to identify best responders to a multidomain rehabilitation treatment. Increased neural reserve, especially in the parietal areas, is also relevant for the compensatory mechanisms activated by rehabilitative treatment. These data are relevant to support clinical decision by identifying target patients with high probability of success after rehabilitative programs on cognitive and behavioral functioning.
format article
author Sonia Di Tella
Sonia Di Tella
Monia Cabinio
Sara Isernia
Valeria Blasi
Federica Rossetto
Francesca Lea Saibene
Margherita Alberoni
Maria Caterina Silveri
Maria Caterina Silveri
Sandro Sorbi
Sandro Sorbi
Mario Clerici
Mario Clerici
Francesca Baglio
author_facet Sonia Di Tella
Sonia Di Tella
Monia Cabinio
Sara Isernia
Valeria Blasi
Federica Rossetto
Francesca Lea Saibene
Margherita Alberoni
Maria Caterina Silveri
Maria Caterina Silveri
Sandro Sorbi
Sandro Sorbi
Mario Clerici
Mario Clerici
Francesca Baglio
author_sort Sonia Di Tella
title Neuroimaging Biomarkers Predicting the Efficacy of Multimodal Rehabilitative Intervention in the Alzheimer’s Dementia Continuum Pathology
title_short Neuroimaging Biomarkers Predicting the Efficacy of Multimodal Rehabilitative Intervention in the Alzheimer’s Dementia Continuum Pathology
title_full Neuroimaging Biomarkers Predicting the Efficacy of Multimodal Rehabilitative Intervention in the Alzheimer’s Dementia Continuum Pathology
title_fullStr Neuroimaging Biomarkers Predicting the Efficacy of Multimodal Rehabilitative Intervention in the Alzheimer’s Dementia Continuum Pathology
title_full_unstemmed Neuroimaging Biomarkers Predicting the Efficacy of Multimodal Rehabilitative Intervention in the Alzheimer’s Dementia Continuum Pathology
title_sort neuroimaging biomarkers predicting the efficacy of multimodal rehabilitative intervention in the alzheimer’s dementia continuum pathology
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/8d2868729e464ae38c2aec2f77f23d0a
work_keys_str_mv AT soniaditella neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
AT soniaditella neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
AT moniacabinio neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
AT saraisernia neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
AT valeriablasi neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
AT federicarossetto neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
AT francescaleasaibene neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
AT margheritaalberoni neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
AT mariacaterinasilveri neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
AT mariacaterinasilveri neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
AT sandrosorbi neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
AT sandrosorbi neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
AT marioclerici neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
AT marioclerici neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
AT francescabaglio neuroimagingbiomarkerspredictingtheefficacyofmultimodalrehabilitativeinterventioninthealzheimersdementiacontinuumpathology
_version_ 1718418174663196672